Stocklytics Platform
Asset logo for symbol ICUCW
LMF Acquisition Opportunities
ICUCW5
$0.02arrow_drop_down1.02%-$0.00
Penny Stock
Asset logo for symbol ICUCW
ICUCW5

$0.02

arrow_drop_down1.02%

Income Statement (ICUCW)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
EBIT-$4.45M-$4.66M-$16.50M--$5.72M
EBITDA-$4.20M-$3.15M-$12.55M--$2.78M
gross Profit$68.00K---$0.00
NET Income-$4.47M-$3.23M-$12.69M-$9.87M-$7.42M
total Revenue$68.00K$0.00$0.00$0.00$0.00

Balance Sheet (ICUCW)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
cash Equivalents-----
net Debt-$2.08M$1.96M-$962.00K$8.90M$10.05M
stockholders Equity-$2.05M-$6.90M-$4.47M-$13.87M-$15.90M
total Assets$4.58M$3.46M$7.74M$3.51M$2.24M
total Debt-$3.14M$4.05M-$10.12M
total Liabilities$6.63M$10.36M$12.21M$17.38M$18.15M

Cash Flow (ICUCW)

itemSep 2024Jun 2024Mar 2024Dec 2023Sep 2023
financing Cash Flow$5.90M-$1.01M$8.33M$4.58M$1.39M
free Cash Flow-$5.00M-$2.82M-$3.48M-$4.48M-$1.33M
investing Cash Flow-----
operating Cash Flow-$5.00M-$2.82M-$3.48M-$4.48M-$1.33M

LMF Acquisition Opportunities (ICUCW) Financials

SeaStar Medical Holding Corporation (ICUCW) is a leading medical technology company that specializes in innovative healthcare solutions. The company's financials demonstrate its strong performance and growth in the industry. From the income statement, it can be observed that SeaStar Medical Holding Corporation has generated a significant amount of revenue. The gross profit indicates the company's ability to generate revenue after deducting the cost of goods sold.
One of the key financial metrics, EBIT (Earnings Before Interest and Taxes), provides insights into the operational profitability of SeaStar Medical Holding Corporation. This metric excludes non-operating expenses and income, giving a clearer picture of the company's core operations. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is another important metric that represents the company's operating income before considering non-cash expenses such as depreciation and amortization.
Net income from stockholders reflects the profitability of SeaStar Medical Holding Corporation after accounting for all expenses, including interest and taxes. This metric helps assess the company's ability to generate profits for its shareholders. Additionally, stockholders' equity represents the residual interest in the assets of the company after deducting liabilities. It demonstrates the value of the company to its shareholders.
The balance sheet provides an overview of SeaStar Medical Holding Corporation's financial position. It includes information about the company's total assets, which represent its resources and investments. Total liabilities indicate the company's obligations and debts. Net debt, on the other hand, represents the company's debt minus its cash equivalents, reflecting its ability to meet financial obligations.
Cash flow metrics are essential to understand the liquidity of SeaStar Medical Holding Corporation. Operating cash flow represents the cash generated from the company's core operations, while investing cash flow represents the cash used for investments in assets and acquisitions. Financing cash flow reflects the cash flow related to the company's financing activities, such as raising capital or paying dividends.
Lastly, free cash flow provides insights into the amount of cash available to SeaStar Medical Holding Corporation after deducting capital expenditures. This metric is crucial as it indicates the company's capacity for growth, debt reduction, and potential for shareholder returns. Overall, SeaStar Medical Holding Corporation demonstrates strong financial performance and stability in the medical technology industry.
add LMF Acquisition Opportunities  to watchlist

Keep an eye on LMF Acquisition Opportunities

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Take Your Investments to a Whole New Level